Key statistics
As of last trade, Sarepta Therapeutics Inc (0L35:LSE) traded at 110.56, 40.63% above the 52 week low of 78.62 set on Dec 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 110.56 |
Low | 110.56 |
Bid | -- |
Offer | -- |
Previous close | 110.56 |
Average volume | 3.27k |
---|---|
Shares outstanding | 95.52m |
Free float | 91.34m |
P/E (TTM) | 90.87 |
Market cap | 10.55bn USD |
EPS (TTM) | 1.22 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 19:08 GMT.
More ▼
Press releases
- Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results
- Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress
- Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors
- Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year
- Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼